UC San Diego Health hospitals in Hillcrest and La Jolla have received grades of ‘A’ for excellence in safety and quality for the Fall 2019 Leapfrog Hospital Safety Grade report.
Of the 3.5 million breast cancer survivors in the US, 1 in 5 will be diagnosed with a painful swelling condition called lymphedema, which can occur as a consequence of lymph nodes being removed. UC San Diego Health now offers a novel surgical procedure to help prevent this debilitating condition.
A new computational method can measure the forces cells exert on each other by analyzing time-lapse videos of cell colonies. It could enable researchers to gain fundamental insights into what role intercellular forces play in cellular biology and how they differ in healthy and diseased states.
San Diego-based Predictive Science, Inc. this week released their first forecast for the 2019-2020 influenza season, which typically runs from November through March.
New data from the U.S. Immigration Policy Center at UC San Diego show that many asylum seekers are returned to Mexico despite expressing fears that their persecutors can find and access them there. The asylum seekers also face violence and homelessness as they wait for their immigration hearings.
UC San Diego Health opens a new clinic in Eastlake that offers express care and imaging capabilities with primary care opening late 2019.
A new type of micromotor—powered by ultrasound and steered by magnets—can move around individual cells and microscopic particles in crowded environments without damaging them. It can also be controlled to move over 3D obstacles. The work could open up new possibilities for nanomedicine.
UC San Diego researchers are leading a collaborative effort to understand and develop methods to help rectify hidden biases in healthcare.
An international consortium of nearly 200 plant scientists, including engineers at UC San Diego, has released gene sequences for more than 1100 plant species, the culmination of a nine-year research project. The advance was made possible in large part thanks to new computational tools.
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.